CLINICAL_TRIALS
research
· 2026-04-02
Clinical Trial Update: Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer [Phase 2]
Summary
Clinical trial update describing a Phase 2 study of Linaclotide in patients with colorectal adenoma and colorectal cancer (stages 0–III), currently active but n…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Colorectal Adenoma, Stage 0 Colorectal Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING